Cargando…
Improving preclinical studies through replications
The purpose of preclinical research is to inform the development of novel diagnostics or therapeutics, and the results of experiments on animal models of disease often inform the decision to conduct studies in humans. However, a substantial number of clinical trials fail, even when preclinical studi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817176/ https://www.ncbi.nlm.nih.gov/pubmed/33432925 http://dx.doi.org/10.7554/eLife.62101 |
_version_ | 1783638584808439808 |
---|---|
author | Drude, Natascha Ingrid Martinez Gamboa, Lorena Danziger, Meggie Dirnagl, Ulrich Toelch, Ulf |
author_facet | Drude, Natascha Ingrid Martinez Gamboa, Lorena Danziger, Meggie Dirnagl, Ulrich Toelch, Ulf |
author_sort | Drude, Natascha Ingrid |
collection | PubMed |
description | The purpose of preclinical research is to inform the development of novel diagnostics or therapeutics, and the results of experiments on animal models of disease often inform the decision to conduct studies in humans. However, a substantial number of clinical trials fail, even when preclinical studies have apparently demonstrated the efficacy of a given intervention. A number of large-scale replication studies are currently trying to identify the factors that influence the robustness of preclinical research. Here, we discuss replications in the context of preclinical research trajectories, and argue that increasing validity should be a priority when selecting experiments to replicate and when performing the replication. We conclude that systematically improving three domains of validity – internal, external and translational – will result in a more efficient allocation of resources, will be more ethical, and will ultimately increase the chances of successful translation. |
format | Online Article Text |
id | pubmed-7817176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-78171762021-01-21 Improving preclinical studies through replications Drude, Natascha Ingrid Martinez Gamboa, Lorena Danziger, Meggie Dirnagl, Ulrich Toelch, Ulf eLife Medicine The purpose of preclinical research is to inform the development of novel diagnostics or therapeutics, and the results of experiments on animal models of disease often inform the decision to conduct studies in humans. However, a substantial number of clinical trials fail, even when preclinical studies have apparently demonstrated the efficacy of a given intervention. A number of large-scale replication studies are currently trying to identify the factors that influence the robustness of preclinical research. Here, we discuss replications in the context of preclinical research trajectories, and argue that increasing validity should be a priority when selecting experiments to replicate and when performing the replication. We conclude that systematically improving three domains of validity – internal, external and translational – will result in a more efficient allocation of resources, will be more ethical, and will ultimately increase the chances of successful translation. eLife Sciences Publications, Ltd 2021-01-12 /pmc/articles/PMC7817176/ /pubmed/33432925 http://dx.doi.org/10.7554/eLife.62101 Text en © 2021, Drude et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Medicine Drude, Natascha Ingrid Martinez Gamboa, Lorena Danziger, Meggie Dirnagl, Ulrich Toelch, Ulf Improving preclinical studies through replications |
title | Improving preclinical studies through replications |
title_full | Improving preclinical studies through replications |
title_fullStr | Improving preclinical studies through replications |
title_full_unstemmed | Improving preclinical studies through replications |
title_short | Improving preclinical studies through replications |
title_sort | improving preclinical studies through replications |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817176/ https://www.ncbi.nlm.nih.gov/pubmed/33432925 http://dx.doi.org/10.7554/eLife.62101 |
work_keys_str_mv | AT drudenataschaingrid improvingpreclinicalstudiesthroughreplications AT martinezgamboalorena improvingpreclinicalstudiesthroughreplications AT danzigermeggie improvingpreclinicalstudiesthroughreplications AT dirnaglulrich improvingpreclinicalstudiesthroughreplications AT toelchulf improvingpreclinicalstudiesthroughreplications |